Featured
2 days ago
Tiziana Life Sciences: Advancing Towards Phase II Clinical Trials
Tiziana Life Sciences is making significant progress in advancing its intranasal anti-CD3 monoclonal antibody, foralumab,…
Featured
1 week ago
Antelope Enterprise Holdings CEO, Weilai Zhang, sits down with SmallCapsDaily
SmallCaps Daily Interviews Antelope Enterprise Holdings CEO, Weilai Zhang
Featured
2 weeks ago
Interview: BriaCell CEO William Williams, MD.
SmallCaps Daily Interviews BriaCell CEO, William V. Williams